📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Assessment of Visual Function with Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2/3 Study. (2024)

First Author: Lam BL

Attributed to: Development of AAV gene therapy for blindness caused by cone-rod dystrophy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ophtha.2024.02.023

PubMed Identifier: 38423215

Publication URI: http://europepmc.org/abstract/MED/38423215

Type: Journal Article/Review

Volume: 131

Parent Publication: Ophthalmology

Issue: 9

ISSN: 0161-6420